OCA swung to PBT positive but capex jumped 82% to 40.4% of revenue

Reported NPAT moved further, from -$17.1m to $4.9m (+129.0%), helped by a deeply negative effective tax rate of -383.1% versus 12.5% in the prior comparable.

Operating cash flow rose 12.3% to $79.0m, but capex almost doubled to $53.2m (+82.3%) and lifted to 40.4% of revenue from 22.0%. Free cash flow remained negative at -$8.4m, although management cites a 30.0% improvement on HY25.

Total assets reached NZ$3b, above the supplied historical range (HY23–HY25 mean NZ$2.7b). Gross borrowings fell to $617.6m and net debt/EBITDA eased to 14.7x from 16.2x, while cash on hand declined to $8.6m.

• EBITDA gained $2.9m on a slightly lower revenue base, indicating cost and margin discipline rather than top-line growth. PBT growth of 105.2% is the cleaner operating read because the -383.1% effective tax rate (a tax credit larger than pre-tax profit) inflated NPAT growth by an additional 23.8 percentage points. The economic improvement is the EBITDA uplift, not the headline NPAT swing.

• The investment cycle has accelerated sharply. Capex of $53.2m at 40.4% of revenue, up from 22.0%, consumed almost all of the $79.0m operating cash inflow and left FCF negative. With cash on hand at only $8.6m, ongoing FCF deficits will rely on either villa settlements, debt headroom, or further capex throttling to fund.

• Leverage is improving but still elevated. Net debt/EBITDA of 14.7x (versus 16.2x prior) and total assets above the historical range reflect a capital-heavy retirement-village model where leverage is structurally high; the supplied historical baseline contextualises the deleveraging as gradual rather than transformative.

Management framing centres on three priorities — sales performance, business excellence, and capital management — and states that gearing has reduced to within target range, but no quantified target is provided.

The HY25→FY25 shape (HY25 was 50.9% of full-year revenue) suggests a roughly even split, while NPAT was heavily second-half weighted in FY25 (HY25 was -56.1% of full-year NPAT given the first-half loss). Annualised on the current run rate, revenue would reach $263.3m, broadly similar to FY25's $260.6m, so the current half does not yet evidence top-line acceleration.

That conversion ratio is, however, not a free cash measure: after $53.2m of capex the business produced -$8.4m of FCF, equivalent to -170.0% of NPAT.

The earnings improvement itself looks operating rather than one-off: there are no flagged non-recurring items, EBITDA rose on cost discipline, and segment results show aged care swinging from -$17.6m to $12.0m. The NPAT line, however, is materially flattered by the tax credit — the supplied historical baseline shows the -383.1% effective rate is below the recent range (HY23–HY25 spanned -12.5% to 25.8%), so investors should anchor on PBT growth of 105.2% and the EBITDA uplift rather than the +129.0% NPAT figure.

This briefing cannot assess underlying villa settlement volumes, deferred management fee build, or property revaluation movements, which materially shape both reported earnings and operating cash flow in this sector.